Viloxazine: A review of the literature

T. A. Ban; J. P. McEvoy; W. H. Wilson

doi:10.1159/000468422

Viloxazine: A review of the literature

T. A. Ban, J. P. McEvoy, W. H. Wilson

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

Original language	English (US)
Pages (from-to)	118-123
Number of pages	6
Journal	International Pharmacopsychiatry
Volume	15
Issue number	2
DOIs	https://doi.org/10.1159/000468422
State	Published - 1980
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1159/000468422

Cite this

@article{f4772a04f49e4d9d995e90297028ad87,

title = "Viloxazine: A review of the literature",

abstract = "In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.",

author = "Ban, {T. A.} and McEvoy, {J. P.} and Wilson, {W. H.}",

year = "1980",

doi = "10.1159/000468422",

language = "English (US)",

volume = "15",

pages = "118--123",

journal = "International Pharmacopsychiatry",

issn = "0020-8272",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Viloxazine

T2 - A review of the literature

AU - Ban, T. A.

AU - McEvoy, J. P.

AU - Wilson, W. H.

PY - 1980

Y1 - 1980

N2 - In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

AB - In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.

UR - http://www.scopus.com/inward/record.url?scp=0018966986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018966986&partnerID=8YFLogxK

U2 - 10.1159/000468422

DO - 10.1159/000468422

M3 - Review article

C2 - 7002831

AN - SCOPUS:0018966986

SN - 0020-8272

VL - 15

SP - 118

EP - 123

JO - International Pharmacopsychiatry

JF - International Pharmacopsychiatry

IS - 2

ER -

Viloxazine: A review of the literature

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this